Lipase News and Research

RSS
FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

Scientists reveal inside story of European regulatory review and approval of Glybera

Scientists reveal inside story of European regulatory review and approval of Glybera

Synageva BioPharma reports study results of sebelipase alfa in adults with late onset LAL Deficiency

Synageva BioPharma reports study results of sebelipase alfa in adults with late onset LAL Deficiency

Xenon Pharmaceuticalsn receives BIOTECanada's Gold Leaf Company of the Year Award for 2013

Xenon Pharmaceuticalsn receives BIOTECanada's Gold Leaf Company of the Year Award for 2013

Single gene therapy session can cure diabetes

Single gene therapy session can cure diabetes

Synageva announces 12-week data from sebelipase alfa Phase I/II study on LAL Deficiency

Synageva announces 12-week data from sebelipase alfa Phase I/II study on LAL Deficiency

TRIP-Br2 plays a major role in energy metabolism and fat storage

TRIP-Br2 plays a major role in energy metabolism and fat storage

Scientists discover new gene mechanism that appears to regulate triglyceride levels

Scientists discover new gene mechanism that appears to regulate triglyceride levels

Ponatinib offers new hope in drug-resistant leukemia

Ponatinib offers new hope in drug-resistant leukemia

Illuminate PatientView to be introduced at Radiological Society of North America meeting

Illuminate PatientView to be introduced at Radiological Society of North America meeting

Study identifies monoacylglycerol lipase as new therapeutic target to treat Alzheimer's

Study identifies monoacylglycerol lipase as new therapeutic target to treat Alzheimer's

High-fat Western diet could lead to development of atherosclerosis

High-fat Western diet could lead to development of atherosclerosis

Novel target identified for fragile X-linked autism

Novel target identified for fragile X-linked autism

Exelix reports preliminary data from cabozantinib phase 1 study on solid tumors

Exelix reports preliminary data from cabozantinib phase 1 study on solid tumors

ApoA-V as a contributor to dyslipidemia in obese children

ApoA-V as a contributor to dyslipidemia in obese children

Newly discovered on/off switch in enzymes may help battle fat-related disease

Newly discovered on/off switch in enzymes may help battle fat-related disease

Resistant starch can help improve insulin sensitivity

Resistant starch can help improve insulin sensitivity

LPL deficiency treatment poised to be first gene therapy in Europe

LPL deficiency treatment poised to be first gene therapy in Europe

uniQure receives positive recommendation from EMA CHMP for Glybera

uniQure receives positive recommendation from EMA CHMP for Glybera

Updated data from ARIAD’s ponatinib pivotal trial on CML or Ph+ ALL

Updated data from ARIAD’s ponatinib pivotal trial on CML or Ph+ ALL